Bioventix PLC (LON:BVXP – Get Free Report) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 2,170.93 and traded as low as GBX 1,750. Bioventix shares last traded at GBX 1,766, with a volume of 1,729 shares changing hands.
Bioventix Stock Down 2.3%
The company has a market capitalization of £88.83 million, a P/E ratio of 11.86 and a beta of 0.35. The firm has a 50-day moving average price of GBX 1,807.37 and a two-hundred day moving average price of GBX 2,170.93.
Insider Buying and Selling at Bioventix
In other Bioventix news, insider Bruce Hiscock acquired 150 shares of the firm’s stock in a transaction that occurred on Tuesday, November 25th. The stock was acquired at an average cost of GBX 2,071 per share, for a total transaction of £3,106.50. 6.16% of the stock is owned by company insiders.
Bioventix Company Profile
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Recommended Stories
- Five stocks we like better than Bioventix
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
- Your Bank Account Is No Longer Safe
- He just nailed another gold prediction …
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
